Nature Research Round Table: Best Practices for the QC of Genome-Edited hPSC Lines - Panel Discussion
In this panel discussion led by Dr. Peter Andrews from the University of Sheffield and Dr. Martin Pera from the Jackson Laboratory, keynote speakers respond to questions from the forum and evaluate consensuses around topics raised in the previous talks.
This panel discussion was part of a Round Table series titled “Challenges in Ensuring hPSC Quality”, hosted in partnership with Nature Research. Global experts gathered at the Springer Nature headquarters in London, UK, to tackle some of the most pertinent issues impacting the use of human pluripotent stem cells (hPSCs), ranging from fundamental biology research to therapeutic applications. Explore the full series here.
This panel discussion was part of a Round Table series titled “Challenges in Ensuring hPSC Quality”, hosted in partnership with Nature Research. Global experts gathered at the Springer Nature headquarters in London, UK, to tackle some of the most pertinent issues impacting the use of human pluripotent stem cells (hPSCs), ranging from fundamental biology research to therapeutic applications. Explore the full series here.
Publish Date: November 01, 2019
Views: 0
Related Multimedia
-
16:56Nature Research Round Table: Identifying Acquired and Background Genetic Variants in Human Pluripotent Stem Cells
Publish Date: November 01, 2019 -
18:48Nature Research Round Table: The Process of Human Pluripotent Stem Cell Adaptation
Publish Date: November 01, 2019 -
15:47Nature Research Round Table: Genomic Integrity of Human Pluripotent Stem Cells
Publish Date: November 01, 2019
Explore Our Products
-
Defined supplement for single-cell cloning of human ES and iPS cells -
Feeder-free, animal component-free culture medium for maintenance of human ES and iPS cells -
qPCR analysis kit for detecting the majority of karyotypic abnormalities reported in human ES and iPS cells -
Enhanced green fluorescent protein (eGFP)-tagged Cas9 nuclease for the generation of double-strand breaks in CRISPR-Cas9 genome editing